Gene Symbol | Gene ID | Gene Info |
---|---|---|
WT1
|
ENSG00000184937.8 | WT1 transcription factor |
MTF1
|
ENSG00000188786.9 | metal regulatory transcription factor 1 |
ZBTB7B
|
ENSG00000160685.9 | zinc finger and BTB domain containing 7B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_38312787_38312938 | MTF1 | 12430 | 0.091962 | -0.91 | 5.5e-04 | Click! |
chr1_38311557_38311777 | MTF1 | 13625 | 0.090412 | -0.82 | 7.1e-03 | Click! |
chr1_38312116_38312382 | MTF1 | 13043 | 0.091163 | -0.80 | 1.0e-02 | Click! |
chr1_38321214_38321365 | MTF1 | 4003 | 0.117186 | -0.78 | 1.2e-02 | Click! |
chr1_38314226_38314377 | MTF1 | 10991 | 0.093902 | -0.60 | 9.0e-02 | Click! |
chr11_32454874_32455186 | WT1 | 1861 | 0.339435 | 0.65 | 6.0e-02 | Click! |
chr11_32354986_32355512 | WT1 | 66912 | 0.122833 | 0.62 | 7.7e-02 | Click! |
chr11_32354706_32354953 | WT1 | 67332 | 0.122000 | 0.45 | 2.2e-01 | Click! |
chr11_32454712_32454863 | WT1 | 2104 | 0.321741 | 0.40 | 2.8e-01 | Click! |
chr11_32454545_32454696 | WT1 | 2261 | 0.312592 | 0.40 | 2.9e-01 | Click! |
chr1_154982220_154982994 | ZBTB7B | 4317 | 0.082530 | -0.88 | 1.8e-03 | Click! |
chr1_154983010_154983161 | ZBTB7B | 3839 | 0.086533 | -0.86 | 3.1e-03 | Click! |
chr1_154986335_154986486 | ZBTB7B | 514 | 0.548657 | -0.80 | 9.6e-03 | Click! |
chr1_154978802_154978989 | ZBTB7B | 3600 | 0.088713 | -0.75 | 2.0e-02 | Click! |
chr1_154986722_154986873 | ZBTB7B | 127 | 0.895324 | -0.73 | 2.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_14924992_14926197 | 10.36 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr2_242497891_242499073 | 7.76 |
BOK-AS1 |
BOK antisense RNA 1 |
90 |
0.79 |
chr7_108095607_108096848 | 7.61 |
NRCAM |
neuronal cell adhesion molecule |
538 |
0.84 |
chr10_79396627_79397649 | 7.55 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
67 |
0.98 |
chr16_85203170_85204140 | 7.09 |
CTC-786C10.1 |
|
1227 |
0.55 |
chr7_45002030_45002849 | 7.01 |
RP4-647J21.1 |
|
1931 |
0.25 |
chr22_46933754_46934840 | 6.33 |
CELSR1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
1230 |
0.46 |
chr17_37856067_37857084 | 6.15 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
242 |
0.86 |
chr2_160918347_160919586 | 6.10 |
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
155 |
0.98 |
chr11_70244216_70245100 | 5.87 |
CTTN |
cortactin |
11 |
0.53 |
chr11_131780761_131781452 | 5.83 |
NTM |
neurotrimin |
209 |
0.95 |
chr1_180881914_180882730 | 5.68 |
KIAA1614 |
KIAA1614 |
3 |
0.98 |
chr1_112532383_112532987 | 5.52 |
KCND3 |
potassium voltage-gated channel, Shal-related subfamily, member 3 |
908 |
0.69 |
chr4_75718841_75720131 | 5.51 |
BTC |
betacellulin |
410 |
0.91 |
chr3_192126971_192127690 | 5.34 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chr7_1709889_1710442 | 5.32 |
ELFN1 |
extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
17590 |
0.18 |
chr16_75284494_75285397 | 5.27 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
100 |
0.96 |
chr5_78985270_78986298 | 5.26 |
CMYA5 |
cardiomyopathy associated 5 |
84 |
0.98 |
chr15_73976688_73977423 | 5.25 |
CD276 |
CD276 molecule |
17 |
0.98 |
chr20_9048816_9049419 | 5.19 |
PLCB4 |
phospholipase C, beta 4 |
293 |
0.9 |
chr10_35102956_35103650 | 5.12 |
PARD3 |
par-3 family cell polarity regulator |
946 |
0.5 |
chr3_126702505_126703684 | 5.09 |
PLXNA1 |
plexin A1 |
4343 |
0.34 |
chr11_118478413_118479735 | 5.09 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
716 |
0.54 |
chr7_95401616_95402462 | 5.06 |
DYNC1I1 |
dynein, cytoplasmic 1, intermediate chain 1 |
123 |
0.98 |
chr1_110693132_110693795 | 5.02 |
SLC6A17 |
solute carrier family 6 (neutral amino acid transporter), member 17 |
355 |
0.81 |
chr9_35489468_35490886 | 5.01 |
RUSC2 |
RUN and SH3 domain containing 2 |
53 |
0.97 |
chr2_191044944_191045899 | 4.96 |
C2orf88 |
chromosome 2 open reading frame 88 |
168 |
0.96 |
chr4_150999769_151000790 | 4.86 |
DCLK2 |
doublecortin-like kinase 2 |
99 |
0.98 |
chr1_33207592_33208218 | 4.85 |
KIAA1522 |
KIAA1522 |
419 |
0.8 |
chr8_69242814_69243988 | 4.83 |
C8orf34 |
chromosome 8 open reading frame 34 |
56 |
0.82 |
chrX_132548696_132549413 | 4.82 |
GPC4 |
glypican 4 |
464 |
0.88 |
chr19_3606102_3607092 | 4.82 |
TBXA2R |
thromboxane A2 receptor |
61 |
0.89 |
chr12_3308931_3310293 | 4.82 |
TSPAN9 |
tetraspanin 9 |
729 |
0.75 |
chr6_54711000_54712080 | 4.77 |
FAM83B |
family with sequence similarity 83, member B |
29 |
0.98 |
chr16_2517636_2518674 | 4.75 |
RP11-715J22.2 |
|
59 |
0.92 |
chr16_86542600_86543872 | 4.69 |
FOXF1 |
forkhead box F1 |
897 |
0.62 |
chr17_7608077_7608845 | 4.65 |
EFNB3 |
ephrin-B3 |
59 |
0.94 |
chr6_19838575_19839711 | 4.59 |
RP1-167F1.2 |
|
168 |
0.95 |
chr16_69140450_69141374 | 4.57 |
HAS3 |
hyaluronan synthase 3 |
400 |
0.81 |
chr2_11622794_11623343 | 4.54 |
E2F6 |
E2F transcription factor 6 |
16793 |
0.13 |
chr4_169753076_169754370 | 4.49 |
RP11-635L1.3 |
|
365 |
0.61 |
chr2_54086905_54087527 | 4.48 |
GPR75-ASB3 |
GPR75-ASB3 readthrough |
46 |
0.37 |
chr22_50745196_50745796 | 4.47 |
PLXNB2 |
plexin B2 |
521 |
0.61 |
chr22_43115644_43116713 | 4.45 |
A4GALT |
alpha 1,4-galactosyltransferase |
24539 |
0.15 |
chr16_2521208_2521831 | 4.45 |
NTN3 |
netrin 3 |
19 |
0.93 |
chr19_460012_460518 | 4.43 |
SHC2 |
SHC (Src homology 2 domain containing) transforming protein 2 |
731 |
0.5 |
chr17_59476045_59476898 | 4.42 |
RP11-332H18.4 |
|
260 |
0.74 |
chr4_187476503_187476829 | 4.36 |
MTNR1A |
melatonin receptor 1A |
55 |
0.7 |
chr8_49782515_49783288 | 4.34 |
SNAI2 |
snail family zinc finger 2 |
51087 |
0.18 |
chr22_45898330_45898748 | 4.33 |
FBLN1 |
fibulin 1 |
173 |
0.96 |
chr9_21974540_21975658 | 4.32 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
2 |
0.97 |
chr8_494526_494820 | 4.31 |
TDRP |
testis development related protein |
164 |
0.97 |
chr19_55684291_55685412 | 4.31 |
SYT5 |
synaptotagmin V |
1083 |
0.28 |
chr5_31193803_31195028 | 4.31 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
558 |
0.85 |
chr19_41725215_41725482 | 4.29 |
AXL |
AXL receptor tyrosine kinase |
208 |
0.89 |
chr3_54155812_54156388 | 4.27 |
CACNA2D3 |
calcium channel, voltage-dependent, alpha 2/delta subunit 3 |
474 |
0.89 |
chr4_183369422_183369983 | 4.27 |
TENM3 |
teneurin transmembrane protein 3 |
450 |
0.89 |
chr5_1110808_1112337 | 4.21 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
578 |
0.75 |
chr10_101088892_101089952 | 4.19 |
CNNM1 |
cyclin M1 |
266 |
0.95 |
chr16_14396121_14396821 | 4.17 |
ENSG00000207639 |
. |
1353 |
0.42 |
chr11_63530349_63531105 | 4.17 |
ENSG00000264519 |
. |
34816 |
0.12 |
chr5_122425011_122425806 | 4.16 |
AC106786.1 |
|
418 |
0.57 |
chr4_55096373_55096991 | 4.14 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
193 |
0.97 |
chr19_6740138_6741070 | 4.13 |
TRIP10 |
thyroid hormone receptor interactor 10 |
325 |
0.81 |
chr4_4388085_4389202 | 4.12 |
NSG1 |
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
189 |
0.96 |
chr16_66878332_66879083 | 4.12 |
CA7 |
carbonic anhydrase VII |
128 |
0.94 |
chr6_46458824_46459774 | 4.11 |
RCAN2 |
regulator of calcineurin 2 |
200 |
0.78 |
chr13_27131903_27132772 | 4.10 |
WASF3 |
WAS protein family, member 3 |
450 |
0.89 |
chr16_67282110_67283381 | 4.07 |
SLC9A5 |
solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 |
108 |
0.89 |
chr17_20491916_20492779 | 4.07 |
CDRT15L2 |
CMT1A duplicated region transcript 15-like 2 |
9310 |
0.21 |
chr11_111169649_111170452 | 4.04 |
COLCA2 |
colorectal cancer associated 2 |
74 |
0.88 |
chr2_236578912_236579455 | 4.04 |
AGAP1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
935 |
0.7 |
chr2_79739509_79740065 | 4.04 |
CTNNA2 |
catenin (cadherin-associated protein), alpha 2 |
339 |
0.91 |
chr12_29936821_29937292 | 4.02 |
TMTC1 |
transmembrane and tetratricopeptide repeat containing 1 |
226 |
0.96 |
chrX_69674453_69675874 | 4.01 |
DLG3 |
discs, large homolog 3 (Drosophila) |
217 |
0.75 |
chr6_34205466_34206794 | 3.99 |
HMGA1 |
high mobility group AT-hook 1 |
438 |
0.85 |
chr13_93879365_93880233 | 3.99 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr6_80656707_80657785 | 3.97 |
ELOVL4 |
ELOVL fatty acid elongase 4 |
51 |
0.98 |
chr7_121513003_121513376 | 3.97 |
PTPRZ1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
46 |
0.99 |
chr17_70118785_70119234 | 3.97 |
SOX9 |
SRY (sex determining region Y)-box 9 |
1848 |
0.5 |
chr7_55087572_55088165 | 3.95 |
EGFR |
epidermal growth factor receptor |
1057 |
0.68 |
chr15_83316430_83317127 | 3.95 |
CPEB1 |
cytoplasmic polyadenylation element binding protein 1 |
50 |
0.76 |
chr3_48631948_48632718 | 3.94 |
COL7A1 |
collagen, type VII, alpha 1 |
260 |
0.83 |
chr1_66258526_66259233 | 3.91 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
15 |
0.99 |
chr10_128594353_128594780 | 3.90 |
DOCK1 |
dedicator of cytokinesis 1 |
588 |
0.8 |
chr1_220101375_220102142 | 3.87 |
SLC30A10 |
solute carrier family 30, member 10 |
186 |
0.95 |
chr19_51161641_51162497 | 3.84 |
C19orf81 |
chromosome 19 open reading frame 81 |
9024 |
0.12 |
chr1_65991038_65991651 | 3.84 |
RP4-630A11.3 |
|
39255 |
0.14 |
chr19_13906290_13907522 | 3.83 |
ZSWIM4 |
zinc finger, SWIM-type containing 4 |
632 |
0.39 |
chr16_51184635_51185066 | 3.82 |
SALL1 |
spalt-like transcription factor 1 |
302 |
0.89 |
chr17_79485709_79486744 | 3.82 |
RP13-766D20.2 |
|
160 |
0.9 |
chr1_48462552_48463006 | 3.81 |
TRABD2B |
TraB domain containing 2B |
212 |
0.96 |
chr17_21279729_21280949 | 3.78 |
KCNJ12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
830 |
0.69 |
chr12_57522507_57523183 | 3.77 |
STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
38 |
0.64 |
chr10_79397825_79398297 | 3.76 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
66 |
0.98 |
chr8_22422542_22423390 | 3.76 |
SORBS3 |
sorbin and SH3 domain containing 3 |
170 |
0.89 |
chr20_4229911_4230312 | 3.75 |
ADRA1D |
adrenoceptor alpha 1D |
390 |
0.89 |
chr1_934275_935357 | 3.73 |
HES4 |
hes family bHLH transcription factor 4 |
545 |
0.57 |
chr6_72129322_72130506 | 3.72 |
ENSG00000207827 |
. |
16590 |
0.22 |
chr11_94473290_94474384 | 3.72 |
RP11-867G2.8 |
|
316 |
0.92 |
chr11_503866_504897 | 3.71 |
RNH1 |
ribonuclease/angiogenin inhibitor 1 |
171 |
0.89 |
chr11_79151624_79152198 | 3.70 |
TENM4 |
teneurin transmembrane protein 4 |
216 |
0.95 |
chr1_31380173_31380807 | 3.69 |
SDC3 |
syndecan 3 |
1118 |
0.44 |
chr15_91500342_91500803 | 3.69 |
RCCD1 |
RCC1 domain containing 1 |
1546 |
0.18 |
chr2_128431846_128432683 | 3.68 |
LIMS2 |
LIM and senescent cell antigen-like domains 2 |
381 |
0.83 |
chr1_29448339_29449190 | 3.67 |
TMEM200B |
transmembrane protein 200B |
249 |
0.93 |
chr9_71939475_71940274 | 3.67 |
FAM189A2 |
family with sequence similarity 189, member A2 |
386 |
0.91 |
chr1_75138923_75139762 | 3.66 |
C1orf173 |
chromosome 1 open reading frame 173 |
80 |
0.98 |
chr22_41633466_41634617 | 3.65 |
CHADL |
chondroadherin-like |
1584 |
0.26 |
chrX_110038687_110039773 | 3.65 |
CHRDL1 |
chordin-like 1 |
56 |
0.99 |
chr16_51185618_51185964 | 3.65 |
SALL1 |
spalt-like transcription factor 1 |
605 |
0.76 |
chr3_33318777_33319866 | 3.63 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr20_55204347_55205219 | 3.62 |
TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
425 |
0.81 |
chrX_12156590_12157176 | 3.62 |
FRMPD4 |
FERM and PDZ domain containing 4 |
298 |
0.9 |
chr2_71127433_71128165 | 3.61 |
VAX2 |
ventral anterior homeobox 2 |
79 |
0.96 |
chr9_127539201_127540134 | 3.61 |
OLFML2A |
olfactomedin-like 2A |
117 |
0.95 |
chr5_159343463_159343902 | 3.60 |
ADRA1B |
adrenoceptor alpha 1B |
108 |
0.98 |
chr17_77019963_77021139 | 3.59 |
C1QTNF1 |
C1q and tumor necrosis factor related protein 1 |
208 |
0.91 |
chr7_132260669_132261651 | 3.57 |
PLXNA4 |
plexin A4 |
69 |
0.98 |
chr8_99439239_99439631 | 3.57 |
KCNS2 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 |
185 |
0.95 |
chr7_100464814_100466140 | 3.56 |
TRIP6 |
thyroid hormone receptor interactor 6 |
717 |
0.47 |
chr16_88450130_88450579 | 3.54 |
ZNF469 |
zinc finger protein 469 |
43525 |
0.15 |
chr5_174178214_174178699 | 3.54 |
ENSG00000266890 |
. |
281 |
0.94 |
chr2_159825200_159826543 | 3.53 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
688 |
0.73 |
chr5_38846105_38846894 | 3.53 |
OSMR |
oncostatin M receptor |
398 |
0.91 |
chr22_37914692_37915408 | 3.52 |
CARD10 |
caspase recruitment domain family, member 10 |
197 |
0.92 |
chr5_128796390_128797012 | 3.51 |
ADAMTS19-AS1 |
ADAMTS19 antisense RNA 1 |
319 |
0.77 |
chr2_236401822_236402641 | 3.50 |
AGAP1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
502 |
0.83 |
chr15_83875578_83876391 | 3.50 |
HDGFRP3 |
Hepatoma-derived growth factor-related protein 3 |
786 |
0.64 |
chr3_64430574_64431219 | 3.49 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
162 |
0.97 |
chr7_45128395_45129126 | 3.48 |
NACAD |
NAC alpha domain containing |
247 |
0.87 |
chr3_173114984_173115853 | 3.48 |
NLGN1 |
neuroligin 1 |
152 |
0.98 |
chr10_118764443_118765166 | 3.47 |
KIAA1598 |
KIAA1598 |
72 |
0.98 |
chr19_45905588_45906146 | 3.47 |
PPP1R13L |
protein phosphatase 1, regulatory subunit 13 like |
2429 |
0.17 |
chr7_29846053_29846716 | 3.47 |
WIPF3 |
WAS/WASL interacting protein family, member 3 |
282 |
0.94 |
chr1_43613126_43613894 | 3.46 |
FAM183A |
family with sequence similarity 183, member A |
84 |
0.96 |
chr18_6729547_6730123 | 3.45 |
ARHGAP28 |
Rho GTPase activating protein 28 |
14 |
0.5 |
chr19_1566819_1567637 | 3.43 |
MEX3D |
mex-3 RNA binding family member D |
301 |
0.76 |
chr4_166794688_166795006 | 3.43 |
TLL1 |
tolloid-like 1 |
45 |
0.99 |
chr8_27491561_27492240 | 3.42 |
SCARA3 |
scavenger receptor class A, member 3 |
202 |
0.93 |
chr6_88875424_88876640 | 3.42 |
CNR1 |
cannabinoid receptor 1 (brain) |
46 |
0.99 |
chr1_241520119_241520816 | 3.40 |
RGS7 |
regulator of G-protein signaling 7 |
63 |
0.99 |
chr15_93615075_93616283 | 3.38 |
RGMA |
repulsive guidance molecule family member a |
695 |
0.78 |
chr6_159239962_159240825 | 3.38 |
EZR |
ezrin |
51 |
0.96 |
chr4_187025490_187026623 | 3.37 |
FAM149A |
family with sequence similarity 149, member A |
175 |
0.94 |
chr9_113341179_113342041 | 3.35 |
SVEP1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
213 |
0.96 |
chr2_127976513_127977351 | 3.34 |
CYP27C1 |
cytochrome P450, family 27, subfamily C, polypeptide 1 |
722 |
0.74 |
chr3_77088826_77089151 | 3.34 |
ROBO2 |
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
49 |
0.99 |
chr7_193532_193958 | 3.33 |
AC093627.12 |
|
435 |
0.67 |
chr5_83680091_83680703 | 3.33 |
CTD-2269F5.1 |
|
23 |
0.71 |
chr1_13910269_13910760 | 3.32 |
PDPN |
podoplanin |
74 |
0.97 |
chr2_113956230_113956830 | 3.32 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
2673 |
0.2 |
chr3_128207705_128209147 | 3.32 |
RP11-475N22.4 |
|
326 |
0.79 |
chr5_63461313_63462499 | 3.31 |
RNF180 |
ring finger protein 180 |
83 |
0.99 |
chr14_69726344_69726819 | 3.31 |
GALNT16 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
100 |
0.98 |
chr3_96531977_96533205 | 3.30 |
EPHA6 |
EPH receptor A6 |
834 |
0.76 |
chr1_29450572_29451688 | 3.30 |
TMEM200B |
transmembrane protein 200B |
683 |
0.7 |
chr9_139940410_139941090 | 3.30 |
NPDC1 |
neural proliferation, differentiation and control, 1 |
95 |
0.89 |
chr2_149894818_149895436 | 3.29 |
LYPD6B |
LY6/PLAUR domain containing 6B |
105 |
0.98 |
chr1_205648469_205649627 | 3.28 |
SLC45A3 |
solute carrier family 45, member 3 |
539 |
0.74 |
chr19_14315927_14317134 | 3.28 |
LPHN1 |
latrophilin 1 |
451 |
0.77 |
chr15_79724653_79725143 | 3.28 |
KIAA1024 |
KIAA1024 |
40 |
0.99 |
chr22_29702254_29703430 | 3.26 |
GAS2L1 |
growth arrest-specific 2 like 1 |
171 |
0.91 |
chr9_140093629_140094566 | 3.24 |
TPRN |
taperin |
460 |
0.53 |
chr5_34656463_34657027 | 3.24 |
RAI14 |
retinoic acid induced 14 |
170 |
0.86 |
chr3_120168709_120169860 | 3.23 |
FSTL1 |
follistatin-like 1 |
554 |
0.84 |
chr22_20119477_20120671 | 3.23 |
ZDHHC8 |
zinc finger, DHHC-type containing 8 |
603 |
0.53 |
chr9_100849786_100850488 | 3.23 |
TRIM14 |
tripartite motif containing 14 |
4706 |
0.2 |
chr22_19165246_19166141 | 3.23 |
SLC25A1 |
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
341 |
0.82 |
chr1_201857755_201858533 | 3.23 |
SHISA4 |
shisa family member 4 |
308 |
0.84 |
chr16_85269227_85269622 | 3.22 |
CTC-786C10.1 |
|
64542 |
0.11 |
chr9_23821130_23821679 | 3.22 |
ELAVL2 |
ELAV like neuron-specific RNA binding protein 2 |
74 |
0.99 |
chr17_34611752_34612896 | 3.21 |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
13395 |
0.14 |
chrX_54947220_54948504 | 3.20 |
TRO |
trophinin |
41 |
0.97 |
chr20_23617810_23618640 | 3.20 |
CST3 |
cystatin C |
357 |
0.87 |
chr11_2949356_2950534 | 3.20 |
PHLDA2 |
pleckstrin homology-like domain, family A, member 2 |
740 |
0.54 |
chr7_73868670_73869167 | 3.19 |
GTF2IRD1 |
GTF2I repeat domain containing 1 |
479 |
0.83 |
chr1_224803774_224804760 | 3.19 |
CNIH3 |
cornichon family AMPA receptor auxiliary protein 3 |
272 |
0.57 |
chr10_105253627_105254375 | 3.19 |
NEURL1 |
neuralized E3 ubiquitin protein ligase 1 |
265 |
0.86 |
chr2_121492823_121493200 | 3.18 |
GLI2 |
GLI family zinc finger 2 |
812 |
0.76 |
chr8_37350646_37351319 | 3.18 |
RP11-150O12.6 |
|
23557 |
0.24 |
chr20_49347136_49348386 | 3.17 |
PARD6B |
par-6 family cell polarity regulator beta |
320 |
0.89 |
chr14_103394355_103395516 | 3.15 |
AMN |
amnion associated transmembrane protein |
211 |
0.92 |
chr20_30457693_30458808 | 3.15 |
DUSP15 |
dual specificity phosphatase 15 |
125 |
0.67 |
chr2_107503115_107503456 | 3.14 |
ST6GAL2 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 |
183 |
0.96 |
chr17_44928914_44929691 | 3.13 |
WNT9B |
wingless-type MMTV integration site family, member 9B |
350 |
0.88 |
chr11_110582275_110583137 | 3.13 |
ARHGAP20 |
Rho GTPase activating protein 20 |
67 |
0.99 |
chr7_116963139_116963425 | 3.12 |
WNT2 |
wingless-type MMTV integration site family member 2 |
61 |
0.98 |
chr3_190580567_190581193 | 3.12 |
GMNC |
geminin coiled-coil domain containing |
476 |
0.9 |
chr6_46702576_46703631 | 3.11 |
PLA2G7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
24 |
0.97 |
chr11_66102741_66104078 | 3.11 |
RIN1 |
Ras and Rab interactor 1 |
468 |
0.53 |
chr7_5633856_5634336 | 3.11 |
FSCN1 |
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) |
82 |
0.97 |
chr7_150779695_150780926 | 3.11 |
TMUB1 |
transmembrane and ubiquitin-like domain containing 1 |
9 |
0.94 |
chr14_24837426_24838101 | 3.09 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
216 |
0.85 |
chr15_96888963_96889465 | 3.09 |
ENSG00000222651 |
. |
12724 |
0.15 |
chr17_15689649_15690074 | 3.09 |
ENSG00000251829 |
. |
4206 |
0.19 |
chr9_140500205_140501463 | 3.09 |
ARRDC1 |
arrestin domain containing 1 |
679 |
0.56 |
chr4_3464595_3465199 | 3.09 |
DOK7 |
docking protein 7 |
136 |
0.96 |
chr8_15094580_15095009 | 3.08 |
SGCZ |
sarcoglycan, zeta |
1054 |
0.7 |
chr3_8809480_8810320 | 3.08 |
OXTR |
oxytocin receptor |
463 |
0.76 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 11.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
4.8 | 14.4 | GO:0060677 | ureteric bud elongation(GO:0060677) |
4.5 | 13.6 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
4.4 | 8.8 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
4.4 | 13.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
3.5 | 14.0 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
3.5 | 10.4 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
3.4 | 13.6 | GO:0072070 | loop of Henle development(GO:0072070) |
3.3 | 13.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
3.2 | 9.7 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
3.1 | 12.4 | GO:0070141 | response to UV-A(GO:0070141) |
3.0 | 9.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
2.9 | 8.7 | GO:0051451 | myoblast migration(GO:0051451) |
2.9 | 8.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
2.8 | 2.8 | GO:0072179 | nephric duct formation(GO:0072179) |
2.8 | 8.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
2.8 | 8.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
2.7 | 2.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
2.6 | 5.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
2.4 | 7.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
2.4 | 2.4 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
2.3 | 6.8 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
2.3 | 4.5 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
2.2 | 2.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
2.2 | 8.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.2 | 4.3 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
2.1 | 2.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
2.1 | 2.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.1 | 6.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
2.1 | 6.3 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
2.1 | 6.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
2.0 | 6.1 | GO:0060596 | mammary placode formation(GO:0060596) |
2.0 | 12.1 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
2.0 | 6.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.0 | 6.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
2.0 | 5.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
2.0 | 5.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.9 | 3.9 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
1.9 | 3.8 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.9 | 3.8 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
1.8 | 1.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.8 | 7.3 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
1.8 | 7.3 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
1.8 | 1.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.8 | 5.4 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
1.8 | 5.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.8 | 1.8 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.8 | 1.8 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
1.8 | 5.3 | GO:0010842 | retina layer formation(GO:0010842) |
1.8 | 7.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
1.7 | 3.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.7 | 5.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.6 | 9.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
1.6 | 1.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
1.6 | 1.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.5 | 12.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
1.5 | 9.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.5 | 4.5 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.5 | 6.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.5 | 5.9 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
1.5 | 3.0 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
1.5 | 4.4 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
1.4 | 5.8 | GO:0010662 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
1.4 | 1.4 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
1.4 | 5.7 | GO:0008218 | bioluminescence(GO:0008218) |
1.4 | 2.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.4 | 2.8 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
1.4 | 4.1 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.4 | 1.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.4 | 4.1 | GO:0009648 | photoperiodism(GO:0009648) |
1.3 | 3.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.3 | 2.6 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
1.3 | 2.6 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
1.3 | 5.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.3 | 3.8 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
1.3 | 3.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) camera-type eye photoreceptor cell differentiation(GO:0060219) |
1.3 | 3.8 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.2 | 2.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
1.2 | 1.2 | GO:0060039 | pericardium development(GO:0060039) |
1.2 | 3.6 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.2 | 1.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.2 | 1.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.2 | 2.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
1.2 | 3.5 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
1.2 | 2.3 | GO:0060437 | lung growth(GO:0060437) |
1.1 | 14.9 | GO:0035329 | hippo signaling(GO:0035329) |
1.1 | 4.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.1 | 7.8 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.1 | 1.1 | GO:0050942 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.1 | 6.6 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
1.1 | 1.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.1 | 1.1 | GO:0060435 | bronchiole development(GO:0060435) |
1.1 | 1.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.1 | 1.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
1.1 | 9.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
1.1 | 20.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
1.1 | 3.2 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
1.1 | 3.2 | GO:0060438 | trachea development(GO:0060438) |
1.1 | 3.2 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
1.1 | 3.2 | GO:0022605 | oogenesis stage(GO:0022605) |
1.1 | 3.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.1 | 3.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.1 | 6.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.1 | 15.9 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
1.1 | 3.2 | GO:0034201 | response to oleic acid(GO:0034201) |
1.0 | 7.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
1.0 | 5.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.0 | 1.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.0 | 1.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.0 | 3.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.0 | 3.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
1.0 | 2.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.0 | 3.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.0 | 3.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.0 | 3.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
1.0 | 13.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.0 | 1.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.0 | 4.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
1.0 | 4.9 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.0 | 1.0 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.0 | 1.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.0 | 5.8 | GO:0016264 | gap junction assembly(GO:0016264) |
1.0 | 1.9 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
1.0 | 3.8 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.9 | 5.7 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.9 | 4.7 | GO:0015871 | choline transport(GO:0015871) |
0.9 | 2.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.9 | 2.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 6.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.9 | 2.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.9 | 1.8 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.9 | 1.8 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.9 | 5.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.9 | 4.5 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.9 | 7.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.9 | 4.5 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.9 | 3.5 | GO:0060013 | righting reflex(GO:0060013) |
0.9 | 6.2 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.9 | 6.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.9 | 0.9 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.9 | 1.7 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.9 | 6.0 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.9 | 7.7 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.8 | 3.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.8 | 0.8 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.8 | 4.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.8 | 1.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.8 | 2.5 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.8 | 12.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.8 | 2.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.8 | 9.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.8 | 1.6 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.8 | 4.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.8 | 2.4 | GO:0014706 | striated muscle tissue development(GO:0014706) |
0.8 | 1.6 | GO:0050955 | thermoception(GO:0050955) |
0.8 | 9.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.8 | 0.8 | GO:0021854 | hypothalamus development(GO:0021854) |
0.8 | 2.4 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.8 | 2.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.8 | 3.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.8 | 2.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.8 | 3.9 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.8 | 2.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.8 | 0.8 | GO:0042637 | catagen(GO:0042637) |
0.8 | 1.5 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.8 | 1.5 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.8 | 3.8 | GO:0032288 | myelin assembly(GO:0032288) |
0.7 | 1.5 | GO:0001880 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.7 | 5.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.7 | 5.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.7 | 2.2 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.7 | 0.7 | GO:0060214 | endocardium formation(GO:0060214) |
0.7 | 3.0 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.7 | 3.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.7 | 5.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.7 | 8.0 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.7 | 1.4 | GO:0043552 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.7 | 1.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.7 | 0.7 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.7 | 4.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.7 | 2.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.7 | 2.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 2.1 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.7 | 3.5 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.7 | 2.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.7 | 2.8 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.7 | 1.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.7 | 1.4 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.7 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.7 | 6.0 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.7 | 2.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.7 | 0.7 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.7 | 3.3 | GO:0043954 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.7 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.7 | 2.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.7 | 0.7 | GO:0042220 | response to cocaine(GO:0042220) |
0.7 | 4.6 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.6 | 3.2 | GO:0007616 | long-term memory(GO:0007616) |
0.6 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 2.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.6 | 1.3 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.6 | 2.5 | GO:0060009 | Sertoli cell differentiation(GO:0060008) Sertoli cell development(GO:0060009) |
0.6 | 1.3 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.6 | 0.6 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.6 | 0.6 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.6 | 6.9 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.6 | 0.6 | GO:0033197 | response to vitamin E(GO:0033197) |
0.6 | 1.2 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.6 | 0.6 | GO:0001660 | fever generation(GO:0001660) |
0.6 | 1.9 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.6 | 1.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 2.5 | GO:0001757 | somite specification(GO:0001757) |
0.6 | 0.6 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.6 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.6 | 1.8 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.6 | 1.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.6 | 1.2 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 0.6 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 4.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.6 | 2.4 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.6 | 2.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.6 | 0.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.6 | 2.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.6 | 2.4 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.6 | 8.8 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.6 | 1.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.6 | 1.8 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.6 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 2.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.6 | 1.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.6 | 0.6 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.6 | 5.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 3.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.6 | 6.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.6 | 7.4 | GO:0007613 | memory(GO:0007613) |
0.6 | 2.8 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.6 | 1.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.6 | 1.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.6 | 10.5 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.6 | 1.1 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.5 | 0.5 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.5 | 3.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 3.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 2.7 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.5 | 1.6 | GO:0032610 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.5 | 0.5 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.5 | 3.8 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.5 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 3.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.5 | 1.6 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.5 | 2.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.5 | 3.7 | GO:0060350 | endochondral bone morphogenesis(GO:0060350) |
0.5 | 0.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.5 | 5.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.5 | 9.9 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.5 | 1.0 | GO:0044256 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.5 | 1.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.5 | 0.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 5.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.5 | 0.5 | GO:0001885 | endothelial cell development(GO:0001885) |
0.5 | 1.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.5 | 1.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 1.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.5 | 0.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 9.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.5 | 2.5 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.5 | 4.5 | GO:0048265 | response to pain(GO:0048265) |
0.5 | 3.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.5 | 1.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.5 | 5.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.5 | 1.0 | GO:0090102 | cochlea development(GO:0090102) |
0.5 | 2.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.5 | 7.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.5 | 0.5 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.5 | 0.5 | GO:0046084 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.5 | 0.5 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.5 | 1.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 4.8 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.5 | 0.5 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.5 | 2.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.5 | 4.7 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.5 | 0.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.5 | 6.1 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.5 | 1.8 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.5 | 4.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.5 | 1.8 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.5 | 1.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.5 | 2.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.5 | 2.7 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.5 | 1.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.5 | 1.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 4.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.4 | 0.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 2.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 1.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 5.8 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.4 | 7.5 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.4 | 2.2 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.4 | 0.4 | GO:1903514 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.4 | 7.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 1.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.4 | 2.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.4 | 1.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.4 | 0.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.7 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.4 | 0.9 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.4 | 3.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 0.4 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.4 | 1.7 | GO:0021983 | pituitary gland development(GO:0021983) |
0.4 | 0.4 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.4 | 2.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.4 | 3.0 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.4 | 4.6 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.4 | 3.8 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 2.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.4 | 51.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 7.1 | GO:0001764 | neuron migration(GO:0001764) |
0.4 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.4 | 0.4 | GO:0031652 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.4 | 1.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.4 | 0.8 | GO:0008354 | germ cell migration(GO:0008354) |
0.4 | 1.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 6.2 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.4 | 0.8 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.4 | 2.9 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.4 | 1.2 | GO:0043113 | receptor clustering(GO:0043113) |
0.4 | 2.0 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.4 | 0.8 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.4 | 2.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 2.4 | GO:0060563 | neuroepithelial cell differentiation(GO:0060563) |
0.4 | 0.4 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.4 | 3.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.4 | 2.0 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.4 | 0.4 | GO:0045986 | relaxation of smooth muscle(GO:0044557) negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 9.8 | GO:0046847 | filopodium assembly(GO:0046847) |
0.4 | 2.3 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.4 | 0.8 | GO:0072273 | metanephric nephron morphogenesis(GO:0072273) |
0.4 | 1.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.4 | 3.0 | GO:0007530 | sex determination(GO:0007530) |
0.4 | 1.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.4 | 1.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.4 | 3.4 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.4 | 1.5 | GO:0030325 | adrenal gland development(GO:0030325) |
0.4 | 0.8 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.4 | 8.2 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.4 | 1.5 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.4 | 2.6 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.4 | 2.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.4 | 1.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 1.5 | GO:0080111 | DNA demethylation(GO:0080111) |
0.4 | 1.5 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.4 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) negative regulation of receptor activity(GO:2000272) |
0.4 | 2.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.4 | 1.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.4 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.4 | 1.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.4 | 23.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.4 | 0.7 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.4 | 0.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.4 | 0.4 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 3.2 | GO:0072164 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.4 | 95.6 | GO:0007409 | axonogenesis(GO:0007409) |
0.4 | 1.8 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.4 | 1.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.4 | 0.4 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 0.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 3.5 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.3 | 0.7 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 7.5 | GO:0051216 | cartilage development(GO:0051216) |
0.3 | 1.4 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.3 | 19.1 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.3 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.7 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.3 | 4.7 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.3 | 0.7 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.7 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.3 | 0.7 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.3 | 0.3 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.3 | 4.3 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.3 | 46.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.3 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 0.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 2.6 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.3 | 1.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 2.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.6 | GO:0007549 | dosage compensation(GO:0007549) |
0.3 | 0.6 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.3 | 1.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.3 | 2.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 3.7 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.3 | 0.3 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.3 | 3.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 6.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.3 | GO:0046958 | nonassociative learning(GO:0046958) |
0.3 | 1.5 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.3 | 1.8 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 0.9 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.3 | 1.2 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.3 | 0.6 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.3 | 2.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 0.3 | GO:0007431 | salivary gland development(GO:0007431) |
0.3 | 1.2 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 11.9 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 2.1 | GO:0001709 | cell fate determination(GO:0001709) |
0.3 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.3 | 4.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 0.3 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.3 | 2.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.6 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.3 | 2.3 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
0.3 | 0.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.6 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 1.7 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.3 | 0.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 0.3 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.3 | 0.3 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.3 | 2.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.3 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.3 | 0.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.3 | 0.3 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.3 | 1.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.3 | 0.5 | GO:0090504 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.3 | 0.3 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.3 | 2.7 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.3 | 0.5 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.3 | 2.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 2.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.5 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 0.5 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.3 | 1.6 | GO:0015904 | tetracycline transport(GO:0015904) |
0.3 | 2.3 | GO:0007492 | endoderm development(GO:0007492) |
0.3 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 1.0 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.3 | 0.8 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.3 | 0.8 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) ventral spinal cord development(GO:0021517) |
0.2 | 0.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.2 | 3.5 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.2 | 0.7 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 1.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 1.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 5.7 | GO:0007588 | excretion(GO:0007588) |
0.2 | 0.2 | GO:0030878 | thyroid gland development(GO:0030878) |
0.2 | 3.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 4.2 | GO:0006885 | regulation of pH(GO:0006885) |
0.2 | 2.6 | GO:0032400 | melanosome localization(GO:0032400) |
0.2 | 0.5 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.2 | 1.9 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.2 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 2.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 1.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.2 | 1.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 1.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 1.6 | GO:0048839 | inner ear development(GO:0048839) |
0.2 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 2.7 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.2 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.2 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 5.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.7 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.4 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.2 | 0.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 1.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 0.6 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 4.1 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.2 | 0.2 | GO:0006949 | syncytium formation(GO:0006949) |
0.2 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 1.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 2.3 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.2 | GO:0042538 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) positive regulation of cellular pH reduction(GO:0032849) hyperosmotic salinity response(GO:0042538) |
0.2 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.2 | GO:0002064 | epithelial cell development(GO:0002064) |
0.2 | 7.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 0.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 2.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 1.4 | GO:0033189 | response to vitamin A(GO:0033189) |
0.2 | 3.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.2 | 0.4 | GO:0043586 | tongue development(GO:0043586) tongue morphogenesis(GO:0043587) |
0.2 | 1.0 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 1.9 | GO:0046888 | negative regulation of hormone secretion(GO:0046888) |
0.2 | 3.8 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.2 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.2 | 0.6 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.2 | 1.9 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 1.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.2 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.2 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 1.0 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 1.2 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.2 | 0.2 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.2 | 0.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.3 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.7 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.2 | 3.7 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.2 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 1.4 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.2 | 0.8 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.5 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.5 | GO:0007512 | adult heart development(GO:0007512) |
0.2 | 0.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.6 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.2 | 0.2 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.2 | 0.3 | GO:0035272 | exocrine system development(GO:0035272) |
0.2 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.9 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 1.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 1.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.9 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.8 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 1.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 13.2 | GO:0061061 | muscle structure development(GO:0061061) |
0.1 | 0.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.4 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.1 | 0.4 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.1 | 0.4 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.8 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 1.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 2.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 6.5 | GO:0034330 | cell junction organization(GO:0034330) |
0.1 | 0.8 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.1 | 0.1 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.1 | 1.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 1.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.1 | GO:0021536 | diencephalon development(GO:0021536) |
0.1 | 0.5 | GO:0090132 | epithelial cell migration(GO:0010631) epithelium migration(GO:0090132) |
0.1 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.4 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 1.0 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.5 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 1.7 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.1 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 6.5 | GO:0001525 | angiogenesis(GO:0001525) |
0.1 | 1.1 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.4 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.6 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.2 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.1 | 0.1 | GO:0048806 | genitalia development(GO:0048806) |
0.1 | 1.1 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 0.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.4 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.6 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.5 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.5 | GO:0098754 | detoxification(GO:0098754) |
0.1 | 0.3 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.1 | 0.8 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.4 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:0032634 | interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
0.1 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.1 | GO:0021675 | nerve development(GO:0021675) |
0.1 | 0.9 | GO:0071772 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.1 | 0.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.1 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.1 | GO:0048645 | organ formation(GO:0048645) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.1 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 2.4 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 1.6 | GO:0001501 | skeletal system development(GO:0001501) |
0.0 | 0.1 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.1 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 3.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.0 | 0.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 1.1 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:0034447 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.0 | GO:0031848 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.4 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0007004 | telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.1 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) methionine biosynthetic process(GO:0009086) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 1.5 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0043588 | skin development(GO:0043588) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
2.5 | 7.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.2 | 13.0 | GO:0010369 | chromocenter(GO:0010369) |
1.9 | 7.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.8 | 1.8 | GO:0043260 | laminin-11 complex(GO:0043260) |
1.6 | 8.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.5 | 4.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.5 | 3.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.5 | 10.2 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
1.4 | 5.5 | GO:0030673 | axolemma(GO:0030673) |
1.3 | 4.0 | GO:0070852 | cell body fiber(GO:0070852) |
1.3 | 4.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.3 | 4.0 | GO:0033270 | paranode region of axon(GO:0033270) |
1.3 | 6.6 | GO:0071437 | invadopodium(GO:0071437) |
1.3 | 10.5 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
1.2 | 7.5 | GO:0001527 | microfibril(GO:0001527) |
1.2 | 3.7 | GO:0032449 | CBM complex(GO:0032449) |
1.2 | 3.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.2 | 4.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
1.2 | 4.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.2 | 6.9 | GO:0031512 | motile primary cilium(GO:0031512) |
1.1 | 4.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.1 | 18.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.1 | 2.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
1.1 | 21.1 | GO:0005581 | collagen trimer(GO:0005581) |
1.0 | 2.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.0 | 3.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 3.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
1.0 | 6.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.0 | 2.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.9 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 8.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 9.7 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.8 | 6.4 | GO:0043034 | costamere(GO:0043034) |
0.8 | 205.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.8 | 1.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.8 | 46.3 | GO:0030426 | growth cone(GO:0030426) |
0.8 | 0.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.7 | 16.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.7 | 2.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.7 | 1.5 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.7 | 12.5 | GO:0030057 | desmosome(GO:0030057) |
0.7 | 0.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.7 | 3.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 3.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 14.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 1.8 | GO:0002102 | podosome(GO:0002102) |
0.6 | 43.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.6 | 3.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.6 | 29.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.6 | 0.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.6 | 58.7 | GO:0070161 | anchoring junction(GO:0070161) |
0.5 | 4.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 4.9 | GO:0030315 | T-tubule(GO:0030315) |
0.5 | 7.5 | GO:0044447 | axoneme part(GO:0044447) |
0.5 | 5.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 40.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.5 | 1.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 2.7 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 10.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 1.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 3.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 50.7 | GO:0005911 | cell-cell junction(GO:0005911) |
0.4 | 15.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 8.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 1.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 2.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.4 | 41.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 3.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 1.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 3.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 0.6 | GO:0044217 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.3 | 1.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 6.6 | GO:0030018 | Z disc(GO:0030018) |
0.3 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 22.5 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 2.4 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 3.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 1.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 3.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.3 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 3.5 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 27.8 | GO:0045202 | synapse(GO:0045202) |
0.2 | 3.7 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.9 | GO:0044421 | extracellular region part(GO:0044421) |
0.2 | 1.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 129.4 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 12.6 | GO:0030425 | dendrite(GO:0030425) |
0.2 | 0.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 1.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 166.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.2 | 1.0 | GO:0000801 | central element(GO:0000801) |
0.2 | 8.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 2.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 6.2 | GO:0030017 | sarcomere(GO:0030017) |
0.2 | 2.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 38.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 132.0 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 3.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.1 | 3.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 1.4 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 2.7 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 6.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 6.5 | GO:0005792 | obsolete microsome(GO:0005792) |
0.1 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.5 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 2.0 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 4.8 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.1 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 183.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 1.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.7 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 2.0 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 1.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
3.2 | 25.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
2.8 | 8.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
2.6 | 7.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.5 | 7.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.5 | 10.0 | GO:0048495 | Roundabout binding(GO:0048495) |
2.5 | 14.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.2 | 15.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
2.1 | 35.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.0 | 5.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.0 | 7.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.0 | 5.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.9 | 5.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.9 | 5.7 | GO:0005113 | patched binding(GO:0005113) |
1.9 | 17.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
1.9 | 7.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.8 | 8.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.8 | 5.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.7 | 5.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.7 | 8.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.6 | 4.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.6 | 14.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.6 | 1.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.6 | 4.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.6 | 4.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.6 | 3.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.5 | 6.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
1.4 | 4.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
1.4 | 9.8 | GO:0030506 | ankyrin binding(GO:0030506) |
1.4 | 1.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.4 | 7.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.4 | 4.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
1.4 | 5.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.3 | 4.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.3 | 5.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.3 | 5.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.3 | 2.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.3 | 3.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.3 | 5.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.2 | 4.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.2 | 8.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.2 | 3.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.2 | 3.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.2 | 26.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.2 | 3.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 3.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.1 | 4.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.1 | 9.1 | GO:0017166 | vinculin binding(GO:0017166) |
1.1 | 3.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.1 | 8.8 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
1.1 | 4.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.1 | 6.5 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
1.1 | 1.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.1 | 77.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.1 | 3.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.1 | 3.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.1 | 7.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.1 | 2.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
1.0 | 6.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.0 | 3.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.0 | 3.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
1.0 | 10.9 | GO:0030553 | cGMP binding(GO:0030553) |
1.0 | 8.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
1.0 | 6.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.0 | 2.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.0 | 5.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 3.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.9 | 11.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.9 | 1.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.9 | 5.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.9 | 3.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.9 | 11.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.9 | 3.7 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.9 | 2.7 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.9 | 14.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.9 | 3.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 4.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.9 | 8.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.9 | 2.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.9 | 5.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.8 | 2.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.8 | 2.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.8 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
0.8 | 0.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 7.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.8 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 4.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.8 | 8.7 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.8 | 2.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.8 | 4.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.8 | 3.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.8 | 3.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 3.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.8 | 6.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 20.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.8 | 3.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 2.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.7 | 2.2 | GO:0008061 | chitin binding(GO:0008061) |
0.7 | 13.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.7 | 3.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 0.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.7 | 5.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.7 | 5.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 5.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.7 | 2.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 2.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.7 | 9.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.7 | 0.7 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.7 | 0.7 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.7 | 3.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.7 | 11.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 2.0 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.7 | 11.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.7 | 2.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 5.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.6 | 2.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.6 | 3.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.6 | 2.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.6 | 3.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 1.9 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.6 | 0.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.6 | 12.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 5.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.6 | 3.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 1.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 3.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.6 | 3.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 9.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.6 | 4.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.6 | 2.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 1.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.6 | 1.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 2.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 1.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 1.2 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 5.1 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 2.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.6 | 14.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.6 | 5.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 6.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.6 | 1.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 6.6 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.5 | 1.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.5 | 1.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 1.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 2.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.5 | 2.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 5.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 4.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 2.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 7.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.5 | 2.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 4.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 1.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 0.5 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.5 | 1.6 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.5 | 3.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.5 | 1.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 13.2 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 1.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 7.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 21.6 | GO:0005178 | integrin binding(GO:0005178) |
0.5 | 24.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.5 | 1.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 1.4 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.5 | 1.9 | GO:0005534 | galactose binding(GO:0005534) |
0.5 | 1.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 2.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.5 | 53.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.5 | 5.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 1.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 1.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.5 | 1.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 3.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 1.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 4.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.5 | 3.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 7.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.5 | 2.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.5 | 5.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.5 | 1.4 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.4 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 2.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 1.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 3.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 1.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 6.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.4 | 1.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 2.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 4.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 41.9 | GO:0005267 | potassium channel activity(GO:0005267) |
0.4 | 1.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 1.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 25.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 1.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 1.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 5.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.4 | 2.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.4 | 1.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 1.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.4 | 4.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 98.1 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.3 | 1.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.3 | 6.2 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.3 | 2.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 3.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 1.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.3 | 1.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 2.6 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 1.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 3.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 1.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 4.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.3 | 1.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.3 | 7.0 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.3 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 2.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 0.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 27.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 3.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 2.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 1.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 0.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 1.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 1.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 0.9 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.3 | 8.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 8.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 2.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 2.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 2.5 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.3 | 0.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 0.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 3.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 1.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 2.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 6.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 1.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 3.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.8 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.3 | 0.8 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.3 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 1.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 11.9 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 2.7 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 1.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.7 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 2.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 2.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 0.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 2.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 1.9 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 1.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.6 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 2.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.2 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 13.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.2 | 2.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.2 | 3.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.4 | GO:0009975 | cyclase activity(GO:0009975) |
0.2 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 4.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 2.7 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 2.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 3.8 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 2.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 1.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 13.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 6.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.5 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.2 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.8 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 0.7 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 0.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 9.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 5.5 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.2 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 3.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 11.8 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 9.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.4 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 1.0 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 1.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
0.1 | 0.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 58.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 2.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 1.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 3.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.5 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.9 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 1.6 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 1.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 3.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 2.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 13.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.1 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 11.2 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 6.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 10.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.6 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.3 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.0 | GO:0005522 | profilin binding(GO:0005522) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 3.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
2.3 | 23.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
2.1 | 31.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.4 | 57.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.2 | 32.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.1 | 34.3 | NABA COLLAGENS | Genes encoding collagen proteins |
1.0 | 21.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.9 | 3.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.9 | 24.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 10.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 13.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.7 | 115.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.7 | 12.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.6 | 9.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 16.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 9.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 7.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 18.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.5 | 14.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 9.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 17.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 20.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.5 | 19.0 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 11.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 3.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 62.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 5.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 79.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 10.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 5.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 2.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 2.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 5.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 6.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 3.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 3.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 1.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 8.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 71.7 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.2 | 8.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 6.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 5.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 6.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 6.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 1.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 24.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
2.3 | 7.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.4 | 27.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
1.4 | 15.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.3 | 36.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 67.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.2 | 18.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.1 | 2.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.1 | 11.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.0 | 21.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.0 | 37.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.0 | 9.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.0 | 2.9 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.9 | 7.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.9 | 3.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.8 | 9.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.8 | 11.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.7 | 2.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 14.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 5.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 8.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.7 | 12.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.7 | 9.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 0.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.7 | 7.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.6 | 5.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 1.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.6 | 12.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 7.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.6 | 1.7 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.6 | 11.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 12.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.6 | 48.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 13.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 2.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 4.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 9.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 11.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 6.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 6.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 21.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 9.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 6.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 2.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.5 | 1.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.5 | 7.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 6.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 5.4 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.4 | 5.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.4 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 9.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 2.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 3.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.4 | 4.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 4.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 10.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.4 | 3.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 16.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 3.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 3.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 4.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 8.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 3.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.3 | 2.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 2.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 2.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 1.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 4.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 3.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 0.9 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 2.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 0.5 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.2 | 1.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 8.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 3.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 17.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 3.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 1.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 1.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 12.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 20.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 3.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 6.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.8 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 1.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 2.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |